<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To examine the association between the angiotensin-converting enzyme (ACE) deletion/insertion (D/I) polymorphism and white matter hyperintensities (WMHs) in patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Observational pilot study with adjustment for potential confounders using analysis of covariance </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Secondary care old-age psychiatry services in greater Manchester, United Kingdom </plain></SENT>
<SENT sid="3" pm="."><plain>PARTICIPANTS: Ninety-seven patients with <z:hpo ids='HP_0000726'>dementia</z:hpo>: 49 with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD, National Institute of Neurological and <z:e sem="disease" ids="C0009460" disease_type="Mental or Behavioral Dysfunction" abbrv="">Communicative Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo>/<z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's Disease</z:e> and Related Disorders Association criteria) and 48 with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD, National Institute of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">Neurological Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo>/Association Internationale pour la Recherche et l'Enseignement en Neurosciences criteria) </plain></SENT>
<SENT sid="4" pm="."><plain>MEASUREMENTS: The ACE D/I polymorphism, WMHs (deep WMHs (DWMHs) and periventricular hyperintensities (PVHs)) on T2-weighted magnetic resonance imaging, and potential cardiovascular confounders </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The D/D polymorphism of the ACE genotype was associated with severity of DWMH (P = .005) but not PVH (P = .34), corrected for age, <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, and type of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Post hoc analyses were limited by statistical power but suggested an interaction with the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E epsilon4 allele </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The results support previous observations that genetic factors influence the development of WMHs in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The involvement of the ACE D/I polymorphism in the pathogenesis of DWMHs in <z:hpo ids='HP_0000726'>dementia</z:hpo> (AD and VaD), by a mechanism that is independent of its association with <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, should be confirmed in a large population-based sample </plain></SENT>
</text></document>